Notify me when Helix Holdings II LLC files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| HLXB | Helix Acquisition Corp. II | Class A ordinary shares, $0.0001 par value per share | 32% | $81,352,890 | 7,389,000 | Bihua Chen | 28 Feb 2025 | ||
| HLXB | BridgeBio Oncology Therapeutics, Inc. | Common Stock | 23% | 17,878,594 | Bihua Chen | 11 Aug 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|